Ablation effects of noninvasive radiofrequency field-induced hyperthermia on liver cancer cells.
To have in-depth analysis of clinical ablation effect of noninvasive radiofrequency field-induced hyperthermia on liver cancer cells, this paper collected liver cancer patients' treatment information from 10 hospitals during January 2010 and December 2011, from which 1050 cases of patients were randomly selected as study object of observation group who underwent noninvasive radiofrequency field-induced hyperthermia treatment; in addition, 500 cases of liver cancer patients were randomly selected as study object of control group who underwent clinical surgical treatment. After treatment was completed, three years of return visit were done, survival rates of the two groups of patients after 1 year, 2 years, and 3 years were compared, and clinical effects of radiofrequency ablation of liver cancer were evaluated. Zoom results show that the two groups are similar in terms of survival rate, and the difference is without statistical significance. 125 patients in observation group had varying degrees of adverse reactions, while 253 patients in control group had adverse reactions. There was difference between groups P < 0.05, with significant statistical significance. It can be concluded that radiofrequency ablation of liver cancer is more secure. Therefore, the results of this study fully demonstrate that liver cancer treatment with noninvasive radiofrequency field-induced hyperthermia is with safety effect and satisfactory survival rate, thus with relatively high clinical value in clinical practice.
Department of Hepatology Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; Department of General Surgery, The Second People's Hospital of Guangdong Province, Guangzhou, China.
Kaiyun
K
Chen
Department of Hepatology Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Shuguang
S
Zhu
Department of General Surgery, The Second People's Hospital of Guangdong Province, Guangzhou, China.
Guoan
G
Xiang
Department of General Surgery, The Second People's Hospital of Guangdong Province, Guangzhou, China.
Xiaopeng
X
Duan
Department of General Surgery, The Second People's Hospital of Guangdong Province, Guangzhou, China.
Jiwen
J
He
Department of Hepatology Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Guihua
G
Chen
Ablation of liver cancer; Clinical efficacy; Non-invasive radiofrequency